The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

WhiteSands Alcohol & Drug Rehab Orlando has published a new educational resource focused on treatment considerations during the Zoloft withdrawal timeline, addressing a topic that affects many ...

Precise MRD™ to transition from research-use-only into a limited clinical launch in March 2026SALT LAKE CITY, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in ...

The Centre amends drug rules, streamlining approval processes and reducing timelines to enhance clinical research and ...

CEO Punit Dhillon highlighted significant progress with the clinical development of nimacimab, including the completion of patient enrollment for the CBeyond Phase IIa trial ahead of schedule. The ...

Site augmentation emerges as a dynamic response to the growing complexity and volume of clinical trials, and the challenge of limited resources at clinical research sites. This support model, which is ...

MIAMI, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation oral ...

Larimar Therapeutics, Inc. has announced a refined timeline for submitting a Biologics License Application (BLA) for its treatment nomlabofusp, aimed at addressing Friedreich's Ataxia (FA). Based on ...

In a major regulatory reform aimed at accelerating pharmaceutical research and easing compliance, the Union ministry of ...

A look at how efficiency, access, platformization, AI, non-traditional players, and regulatory recovery are expected to reshape clinical operations in 2026. As sponsors, CROs, regulators, and ...

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical ...

The Union Ministry of Health and Family Welfare has taken a series of measures including simplification of regulatory ...